These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30371053)

  • 21. αS Oligomers Generated from Interactions with a Polyunsaturated Fatty Acid and a Dopamine Metabolite Differentially Interact with Aβ to Enhance Neurotoxicity.
    Dhakal S; Saha J; Wyant CE; Rangachari V
    ACS Chem Neurosci; 2021 Nov; 12(21):4153-4161. PubMed ID: 34665617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein.
    Israeli E; Sharon R
    J Neurochem; 2009 Jan; 108(2):465-74. PubMed ID: 19012742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Amyloid and α-synuclein cooperate to block SNARE-dependent vesicle fusion.
    Choi BK; Kim JY; Cha MY; Mook-Jung I; Shin YK; Lee NK
    Biochemistry; 2015 Mar; 54(9):1831-40. PubMed ID: 25714795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils.
    Wood A; Chau E; Yang Y; Kim JR
    Appl Biochem Biotechnol; 2020 Apr; 190(4):1411-1424. PubMed ID: 31776941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiolipin Promotes Pore-Forming Activity of Alpha-Synuclein Oligomers in Mitochondrial Membranes.
    Ghio S; Camilleri A; Caruana M; Ruf VC; Schmidt F; Leonov A; Ryazanov S; Griesinger C; Cauchi RJ; Kamp F; Giese A; Vassallo N
    ACS Chem Neurosci; 2019 Aug; 10(8):3815-3829. PubMed ID: 31356747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Synuclein Oligomers Induce a Unique Toxic Tau Strain.
    Castillo-Carranza DL; Guerrero-Muñoz MJ; Sengupta U; Gerson JE; Kayed R
    Biol Psychiatry; 2018 Oct; 84(7):499-508. PubMed ID: 29478699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson's disease.
    Murakami H; Tokuda T; El-Agnaf OMA; Ohmichi T; Miki A; Ohashi H; Owan Y; Saito Y; Yano S; Tsukie T; Ikeuchi T; Ono K
    BMC Neurol; 2019 Jun; 19(1):113. PubMed ID: 31164098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid oligomerization of the Parkinson's disease related protein α-synuclein impacts on its curvature-membrane sensitivity.
    Gallea JI; Ambroggio EE; Vilcaes AA; James NG; Jameson DM; Celej MS
    J Neurochem; 2018 Nov; 147(4):541-556. PubMed ID: 30142705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.
    Gadad BS; Britton GB; Rao KS
    J Alzheimers Dis; 2011; 24 Suppl 2():223-32. PubMed ID: 21460436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative.
    Chau E; Kim H; Shin J; Martinez A; Kim JR
    Biochem Biophys Res Commun; 2021 Oct; 574():85-90. PubMed ID: 34454326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
    Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M
    ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols.
    Camilleri A; Zarb C; Caruana M; Ostermeier U; Ghio S; Högen T; Schmidt F; Giese A; Vassallo N
    Biochim Biophys Acta; 2013 Nov; 1828(11):2532-43. PubMed ID: 23817009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.
    Sengupta U; Guerrero-Muñoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R
    Biol Psychiatry; 2015 Nov; 78(10):672-83. PubMed ID: 25676491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism.
    Limbocker R; Mannini B; Ruggeri FS; Cascella R; Xu CK; Perni M; Chia S; Chen SW; Habchi J; Bigi A; Kreiser RP; Wright AK; Albright JA; Kartanas T; Kumita JR; Cremades N; Zasloff M; Cecchi C; Knowles TPJ; Chiti F; Vendruscolo M; Dobson CM
    Commun Biol; 2020 Aug; 3(1):435. PubMed ID: 32792544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different species of alpha-synuclein oligomers induce calcium influx and seeding.
    Danzer KM; Haasen D; Karow AR; Moussaud S; Habeck M; Giese A; Kretzschmar H; Hengerer B; Kostka M
    J Neurosci; 2007 Aug; 27(34):9220-32. PubMed ID: 17715357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
    Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
    Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
    Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
    Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission electron microscopy characterization of fluorescently labelled amyloid β 1-40 and α-synuclein aggregates.
    Anderson VL; Webb WW
    BMC Biotechnol; 2011 Dec; 11():125. PubMed ID: 22182687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.